Ionica Sciences in the News

An antigen-targeting assay for Lyme disease: Combining aptamers and SERS to detect the OspA protein” accepted for publication in Nanomedicine: Nanoscience, Medicine and Biology

The IonLyme assay, the first application of the IonID platform, identifying and differentiating serum samples from Lyme patients at >90% accuracy.

January 30, 2022
Read Article

NSF Grants Ionica SBIR Phase I Funding to Develop IonCovid – The Next Application of the IonID Platform.

December 1, 2020

FuzeHub shares the success story of Ionica Sciences

July 13, 2020
Read Article

InformNY publishes an article about the new IonLyme test.

September 11, 2019
Read Article

Syracuse’s WSYR highlights the promise of Ionica Sciences’ IonLyme test

September 10, 2019
Watch Video

The Cornell Chronicle explains the advantages of the IonLyme test.

September 4, 2019
Read Article

Awarded Grant for instrumentation purchase from NY State through FuzeHub program.

April 2019
Learn More About FuzeHub

Awarded a Defense Health Agency STTR Phase I in collaboration with The City College of New York – “Rapid SERS-based Detection of Sepsis and TBI Biomarkers.“

February 2018
See Award Details

The Global Lyme Alliance Announces Partnership with Ionica Sciences to Develop New Lyme Disease Diagnostic Test.

October 10, 2017
Read Article

Awarded a grant through the Grants for Growth program from The Tech Garden in Syracuse, NY.

August, 2015
Learn More About Grants for Growth

Awarded an Air Force STTR Phase I – “Real time detection of stress- and fatigue-related biomarkers using vibrational spectroscopy.“

July, 2014
See Award Details

Awarded a DARPA SBIR Phase I – “Surface Enhanced Raman Scattering-Based Oxytocin Quantitation.“

October, 2013
See Award Details

Join Our Mailing List!

Sign up for periodic updates from Ionica Sciences as we continue to innovate disease diagnostics.

You have Successfully Subscribed!